跳至主要内容
临床试验/ACTRN12620000469910
ACTRN12620000469910撤回未知

Randomised Control Trial of Vascular Access Site Closure with FemoSeal™ vs StarClose™ - clinical outcomes and imaging features for patients undergoing angiography

orthern Sydney Local Health District0 个研究点目标入组 300 人开始时间: 2020年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
撤回
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Participants will be recruited from a population undergoing diagnostic and interventional peripheral vascular procedures. Participants undergoing arterial access via the common femoral artery (CFA) with a 6F or 7F sheath, on a single or dual antiplatelet treatment.
  • These participants will be identified pre operatively by study personnel. They will be invited by one of the researchers to participate in the trial. Patient Information Sheets and Consent Forms will be provided to prospective participants for review prior to obtaining consent. If they wish to participate, written informed consent will be obtained and the patient will be enrolled into the study. Participants will have time to consider and withdraw participation from the time they are informed and/or consented for the trial.
  • Inclusion criteria
  • antegrade or retrograde CFA US guided puncture
  • 6F or 7F sheath size
  • CFA diameter >5mm
  • on an antiplatelet agent

排除标准

  • 1. acute limb ischaemia
  • 2. prior open femoral intervention (ie femoral endarterectomy)
  • 3. prior VCD use within 30 days
  • 4. heavily calcified vessel not suitable for VCD
  • 5. bleeding diathesis
  • 6. hypertension with either SBP > 220 or DBP > 110
  • allergy to nitinol or bioabsorable polymer

研究者

发起方
orthern Sydney Local Health District

相似试验